checkAd

    DGAP-News  189  0 Kommentare Highlights from SYNLAB Germany | Protection against COVID-19 at work: SYNLAB introduces new PCR pooling test method for companies - Seite 3

    For individuals in the context of medical diagnostics, especially for symptomatic or suspected individuals, the conventional PCR test is still the gold standard in terms of sensitivity and specificity. Normally, individuals can book appointments for sampling conveniently and promptly and usually receive their results via app within 24 hours.

    - End -

     

    For more information:

    Christian Ries,
    SYNLAB Holding Germany GmbH
    +49 821 52157-210
    christian.ries@synlab.com
     


    About SYNLAB Group

    • SYNLAB Group is the largest European clinical laboratory and medical diagnostic services provider by revenue and number of tests. SYNLAB offers a full range of innovative and reliable medical diagnostics for patients, practising doctors, clinics and the pharmaceutical industry.
    • Providing the leading level of service within the industry, SYNLAB is the partner of choice for diagnostics in human and veterinary medicine. The Group continuously innovates medical diagnostic services for the benefit of patients and customers.
    • SYNLAB operates in 36 countries across four continents and holds leading positions in most markets. More than 20,000 employees (FTE), including over 1,200 medical experts, as well as a large number of other specialists such as biologists, chemists and laboratory technicians, contribute every day to the Group's worldwide success. SYNLAB carries out approximately 500 million laboratory tests per year and achieved Group revenues of EUR 2.6 billion in 2020.
    • More information can be found on www.synlab.com


    03.05.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.dgap.de


    Language: English
    Company: SYNLAB AG
    Moosacher Straße 88
    80809 Munich
    Germany
    Phone: +49 1701183753
    E-mail: ir@synlab.com
    Internet: www.synlab.com/
    ISIN: DE000A2TSL71
    WKN: A2TSL7
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 1191651
    Seite 3 von 4


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News Highlights from SYNLAB Germany | Protection against COVID-19 at work: SYNLAB introduces new PCR pooling test method for companies - Seite 3 DGAP-News: SYNLAB AG / Key word(s): Product Launch Highlights from SYNLAB Germany | Protection against COVID-19 at work: SYNLAB introduces new PCR pooling test method for companies 03.05.2021 / 10:39 The issuer is solely responsible for the …

    Schreibe Deinen Kommentar

    Disclaimer